Senti Biosciences Analyst Ratings
Senti Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2023 | 348.76% | Chardan Capital | $12 → $8 | Maintains | Buy |
| 01/27/2023 | 68.28% | Morgan Stanley | $7.5 → $3 | Maintains | Equal-Weight |
| 12/16/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 10/07/2022 | 320.71% | Morgan Stanley | → $7.5 | Initiates Coverage On | → Equal-Weight |
| 09/29/2022 | 292.66% | B of A Securities | → $7 | Initiates Coverage On | → Buy |
| 09/23/2022 | 573.14% | Chardan Capital | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 01/30/2023 | 348.76% | 查丹資本 | 十二美元 → 8 美元 | 維護 | 購買 |
| 01/27/2023 | 68.28% | 摩根士丹利 | 7 美元 → 3 美元 | 維護 | 同等重量 |
| 12/16/2022 | — | 摩根大通 | 啟動覆蓋範圍 | → 中性 | |
| 2022 年 7 月 10 日 | 320.71% | 摩根士丹利 | → 7 美元 | 啟動覆蓋範圍 | → 同等重量 |
| 09/29/2022 | 292.66% | A 之 B 證券 | → 7 美元 | 啟動覆蓋範圍 | → 購買 |
| 09/23/2022 | 573.14% | 查丹資本 | → 十二美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Senti Biosciences (SNTI)?
森蒂生物科學（SNTI）的目標價格是多少？
The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by Morgan Stanley on January 27, 2023. The analyst firm set a price target for $3.00 expecting SNTI to rise to within 12 months (a possible 68.28% upside). 5 analyst firms have reported ratings in the last year.
摩根士丹利於 2023 年 1 月 27 日報導了森蒂生物科學（納斯達克股票代碼：SNTI）的最新價格目標。該分析師公司設定了 3.00 美元的價格目標，預計 SNTI 將在 12 個月內上升（可能是 68.28％ 的上漲）。5 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Senti Biosciences (SNTI)?
森蒂生物科學（SNTI）的最新分析師評級為何？
The latest analyst rating for Senti Biosciences (NASDAQ: SNTI) was provided by Morgan Stanley, and Senti Biosciences maintained their equal-weight rating.
森蒂生物科學（納斯達克股票代碼：SNTI）的最新分析師評級由摩根士丹利提供，而森蒂生物科學保持其同等權重的評級。
When is the next analyst rating going to be posted or updated for Senti Biosciences (SNTI)?
什麼時候將公佈或更新森蒂生物科學（SNTI）的下一個分析師評級？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Senti Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Senti Biosciences was filed on January 27, 2023 so you should expect the next rating to be made available sometime around January 27, 2024.
分析師在進行了廣泛的研究後到達股票評級，其中包括通過公共財務報表，與 Senti Biosciences 的高管和客戶交談以及收聽盈利會議電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。森蒂生物科學的最後評級於 2023 年 1 月 27 日提交，因此您應該期望下一個評分將在 2024 年 1 月 27 日左右提供。
Is the Analyst Rating Senti Biosciences (SNTI) correct?
分析師評級森蒂生物科學（SNTI）是否正確？
While ratings are subjective and will change, the latest Senti Biosciences (SNTI) rating was a maintained with a price target of $7.50 to $3.00. The current price Senti Biosciences (SNTI) is trading at is $1.78, which is out of the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的森蒂生物科學（SNTI）評級維持，目標價格為 7.50 美元至 3.00 美元。當前價格森蒂生物科學（SNTI）的交易價格為 1.78 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。